Mark McLain
Psychiatry · Ridgeland, MSNPI 1649318486
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 374 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 374 payments — averaging $17.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$723
- Otsuka America Pharmaceutical, Inc.$703
- Supernus Pharmaceuticals, Inc.$528
- Vanda Pharmaceuticals Inc.$480
- Axsome Therapeutics, Inc.$378
- plus $2K from 20 others
What the payments were for
- Food & beverage$6,477100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 110 | $1,544 |
| Takeda Pharmaceuticals U.S.A., Inc. | 50 | $723 |
| Otsuka America Pharmaceutical, Inc. | 36 | $703 |
| Supernus Pharmaceuticals, Inc. | 27 | $528 |
| Vanda Pharmaceuticals Inc. | 20 | $480 |
| Axsome Therapeutics, Inc. | 16 | $378 |
| Lundbeck LLC | 9 | $214 |
| Tris Pharma Inc | 12 | $213 |
| Johnson & Johnson | 14 | $212 |
| Jazz Pharmaceuticals Inc. | 10 | $199 |
| Teva Pharmaceuticals USA, Inc. | 9 | $195 |
| Ironshore Pharmaceuticals Inc. | 9 | $156 |
| Merck | 10 | $154 |
| E.r. Squibb & Sons, L.L.C. | 7 | $153 |
| Eisai Inc. | 9 | $139 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $133 |
| Neurocrine Biosciences, Inc. | 6 | $116 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Avanir Pharmaceuticals, Inc. | 2 | $29 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
| Alfasigma USA, Inc. | 1 | $23 |
| Biogen | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$121
How this compares
$6,477 in reported general payments places this provider in the 90th percentile of 219 psychiatry providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 113 | $5,023 |
| Aripiprazole | 29 | $2,134 |
| Quetiapine Fumarate | 76 | $1,647 |
| Zolpidem Tartrate ErZolpidem Tartrate | 13 | $1,536 |
| Escitalopram Oxalate | 109 | $1,179 |
| Duloxetine Hcl | 60 | $1,105 |
| Oxcarbazepine | 12 | $1,046 |
| Paroxetine Hcl | 67 | $902 |
| Clonazepam | 132 | $897 |
| Fluoxetine Hcl | 70 | $705 |
| Alprazolam | 177 | $696 |
| Trazodone Hcl | 63 | $595 |
| Bupropion Hcl SrBupropion Hcl | 24 | $522 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 27 | $521 |
| Bupropion Hcl | 17 | $415 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Ridgeland
- Kurt BuechlerRidgeland$1.1M
- Clyde GlennRidgeland$68K
- Mark WebbRidgeland$12K
- Susan YoungerRidgeland$8K
- Fawaz AbdrabboRidgeland$4K
- Avani PatelRidgeland$4K
- Maxie GordonClinton$1.3M
- Chasity TorrenceWhitfield$834K
- Jon JacksonJackson$834K
- John NortonJackson$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.